News

FOXO Technologies Implements Strategic Reverse Stock Split

FOXO Technologies Implements Strategic Reverse Stock Split

FOXO Technologies Announces Reverse Stock Split

FOXO Technologies Inc. (NYSE American: FOXO), a prominent player in the biotechnology sector, is taking significant steps to enhance its market presence. The Board of Directors of FOXO recently approved a 1 for 1.99 reverse stock split for its Class A common stock. In straightforward terms, this means that every 1.99 shares currently held by shareholders will automatically be converted into a single share. This decision aims to boost the company's stock price, ensuring compliance with the NYSE American's continued listing requirements.

What to Expect After the Stock Split

The reverse stock split is set to become effective at 4:01 PM ET on a specific date, with trading on the NYSE American expected to commence on a split-adjusted basis shortly thereafter. What does this mean for current shareholders? Most notably, it will help maintain a stock price above the requisite $0.10 per share, an important threshold for remaining listed on the exchange. This adjustment will occur without altering the $0.0001 par value per share, thus preserving shareholder equity at the same time. For those holding fractional shares, their holdings will be rounded up to the nearest whole share following the split.

The Rationale Behind the Reverse Stock Split

FOXO Technologies, through this corporate maneuver, is not only securing its compliance with the NYSE but also optimizing its stock for future growth. This strategic decision underscores FOXO's commitment to positioning itself positively in the competitive biotechnology landscape. The company believes that a higher stock price will not only adhere to regulatory standards but also enhance its visibility and appeal to a broader investor base.

Impact on Company Operations

Importantly, FOXO Technologies has noted that the reverse stock split is not anticipated to affect its ongoing business operations. The company remains focused on enhancing its product offerings and expanding its reach across the biotech industry. Any outstanding convertible preferred stock, warrants, stock options, and equity incentive plans will also be adjusted in line with the split, ensuring uniformity among all stakeholders.

Details About FOXO Technologies Inc.

Often recognized for its innovation, FOXO operates three distinct subsidiaries, each dedicated to different facets of health management and technology. One key operation is Rennova Community Health, which plays a vital role in providing healthcare services through its management of Scott County Community Hospital. This critical access hospital serves the needs of its community in East Tennessee.

Further Operations of FOXO

Another subsidiary, Myrtle Recovery Centers, focuses on behavioral health and offers comprehensive inpatient and outpatient services. Their emphasis on detox and rehabilitation underscores FOXO's commitment to improving human health and wellbeing. Additionally, FOXO Labs is at the forefront of biotechnological advancements, striving to develop cutting-edge product solutions that significantly improve health outcomes.

How Shareholders are Affected

Following the split, all stockholders will see their holdings adjusted accordingly, but their overall ownership percentage will remain largely unchanged. Shareholders holding shares through electronic means will not need to take any action; adjustments will be made automatically. Those with shares held through brokers will have their accounts updated to reflect the new share configuration, thereby simplifying the transition during this time of change.

Continental Stock Transfer's Role

Continental Stock Transfer & Trust Company has been appointed as the exchange agent for this reverse stock split. Their expertise will assure a smooth transition, allowing shareholders to retain their shares without unnecessary complications. The primary goal is to make this process as seamless as possible for all stakeholders involved.

Frequently Asked Questions

What is a reverse stock split?

A reverse stock split is a corporate action where a company reduces the number of its outstanding shares, aiming to increase its stock price.

Why is FOXO Technologies executing a reverse stock split?

The split is intended to comply with NYSE listing requirements and enhance its stock price for better market positioning.

When will the reverse stock split take effect?

The reverse stock split is set to take effect at 4:01 PM ET, with trading on a split-adjusted basis commencing the following day.

How will this affect my shares?

Current shares will be converted at a ratio of 1 for 1.99, with fractional shares being rounded up to the nearest whole number.

Will this impact my ownership in FOXO?

While the number of shares will change, your percentage ownership in the company will generally remain the same except for those with fractional shares.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 65

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 476

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 537

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 446

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 496

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 572

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 213

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 617

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 453

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Transform Your Check Printing with ezCheckPrinting Today

Updated Category News Views 194

Revolutionary Check Printing Solutions for Businesses In today's fast-paced business environment, efficient solutions are essential. One innovative tool that has emerged is the ezCheckPrinting software, combined with a virtual printer, designed specifically for QuickBooks and Quicken users. This powerful combination facilitates unlimited check printing directly onto blank...

Continue Reading
Kelso Technologies' 2025 Strategies for Growth and Stability

Updated Category News Views 488

Kelso Technologies' Strategic Outlook for 2025 Kelso Technologies Inc (TSX: KLS) has outlined its ambitious goals for 2025 amid a recovering economy. The Board of Directors has given the green light to a budget that anticipates a sales growth margin between 0% to 5% compared to the previous fiscal year. The company expects revenues for fiscal year 2024 to reach...

Continue Reading
Revelation Biosciences Launches Clinical Trial for Chronic Kidney Disease

Updated Category News Views 195

Revelation Biosciences Launches PRIME Phase 1b Clinical Study Revelation Biosciences, Inc. is embarking on an exciting chapter as it announces the initiation of its PRIME Phase 1b clinical study aimed at examining the effects of Gemini, a proprietary formulation designed to assist in the treatment of Chronic Kidney Disease (CKD). The company, focused on leveraging the...

Continue Reading
Auction Outcomes for Treasury Bills on November 28, 2024

Updated Category News Views 237

Overview of Treasury Bills Auction Results The auction for treasury bills held on a recent date revealed important data regarding bids, sales, and prices. Investors and market analysts keep a close eye on these outcomes to gauge market conditions and make informed decisions. Detailed Auction Data The following section provides comprehensive details on the bids, sale...

Continue Reading
IMC Rare Earths IPO Debuts Amid Fed Rate Focus

Updated Category News Views 27

Rare Earths and Rate Talks Steal the Spotlight You ever feel like every time you look at the market, something’s ready to pop or drop? Today’s no exception, with IMC Rare Earths making its grand debut while everyone's ears are peeled for the Fed. Now, a fresh pair of dice are rolling on Wall Street, as IMC steps onto the NYSE American. Breaking Down the IMC IPO This...

Continue Reading